News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Linnaeus will use these funds to further develop LNS880.
PCI hosted its annual Innovation @ Penn program at Wharton San Francisco.
The dedicated venture capital fund will invest in early-stage life science companies spun out of Penn.
Ten teams completed the program, and 26 individuals received valuable training in entrepreneurship.
The article discusses how nearly all significant modern medicines originated from taxpayer-funded university research.
The newly expanded 53,000-square-foot biotech incubator, the Philadelphia ATxCC aims to provide emerging startups and biopharma organizations with resources and tech.
The facility, which will support six to eight biotech startups, is set to open next year.
The article details Penn’s focus on sustaining research excellence, strengthening collaboration, and reshaping the University’s research enterprise to further expand its impact.
Penn’s newly developed seven-story facility at 3600 Civic Center Boulevard will bring together labs across disciplines to advance breakthroughs in immune health, autoimmunity, and infectious diseases.
The University of Pennsylvania and Pennsylvania Governor Josh Shapiro’s Office of Administration signed a cooperative agreement.